These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Leishmaniasis of the lip. Veraldi S; Rigoni C; Gianotti R Acta Derm Venereol; 2002; 82(6):469-70. PubMed ID: 12575860 [No Abstract] [Full Text] [Related]
23. Old world cutaneous leishmaniasis in Iran: clinical variants and treatments. Firooz A; Mortazavi H; Khamesipour A; Ghiasi M; Abedini R; Balighi K; Esmaili N; Nassiri-Kashani M; Eskandari SE; Mohebali M; Mir Amin Mohammadi A; Dowlati Y J Dermatolog Treat; 2021 Nov; 32(7):673-683. PubMed ID: 31869258 [TBL] [Abstract][Full Text] [Related]
24. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate. Kuyucu N; Kara C; Bakirtaç A; Teziç T Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679 [TBL] [Abstract][Full Text] [Related]
25. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy. Shamsi Meymandi S; Javadi A; Dabiri S; Shamsi Meymandi M; Nadji M Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate. Shamsi Meymandi S; Zandi S; Aghaie H; Heshmatkhah A J Eur Acad Dermatol Venereol; 2011 May; 25(5):587-91. PubMed ID: 20666876 [TBL] [Abstract][Full Text] [Related]
27. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol. Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102 [No Abstract] [Full Text] [Related]
28. Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications. Layegh P; Khademi Z; Afzal Aghaee M; Moghiman T J Pediatric Infect Dis Soc; 2015 Dec; 4(4):356-8. PubMed ID: 26582874 [TBL] [Abstract][Full Text] [Related]
29. Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis. Arevalo I; Tulliano G; Quispe A; Spaeth G; Matlashewski G; Llanos-Cuentas A; Pollack H Clin Infect Dis; 2007 Jun; 44(12):1549-54. PubMed ID: 17516397 [TBL] [Abstract][Full Text] [Related]
30. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV. Laguna F; López-Vélez R; Soriano V; Montilla P; Alvar J; González-Lahoz JM J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514 [TBL] [Abstract][Full Text] [Related]
31. Unusual manifestation of genital cutaneous leishmaniasis in an immunocompetent patient from São Paulo, Brazil: A case report. Reis LC; Lindoso JAL; Celeste BJ; Braz LMA; Ramos-Sanchez EM; Yamashiro-Kanashiro EH; Goto H; Oyafuso LKM Rev Soc Bras Med Trop; 2021; 54():e0514-2020. PubMed ID: 33759920 [TBL] [Abstract][Full Text] [Related]
32. Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol. Antezana G; Zeballos R; Mendoza C; Lyevre P; Valda L; Cardenas F; Noriega I; Ugarte H; Dedet JP Trans R Soc Trop Med Hyg; 1992; 86(1):31-3. PubMed ID: 1566297 [TBL] [Abstract][Full Text] [Related]
33. A strange infiltrative plaque on the face. Guarneri C; Wollina U; Chokoeva A; Lotti TM; Tchernev G Braz J Infect Dis; 2016; 20(2):214-5. PubMed ID: 26748228 [No Abstract] [Full Text] [Related]
34. [Facial inflammatory cutaneous leishmaniasis or "erysipeloid"]. El Benaye J; Miloudi M; El Haouri M Ann Dermatol Venereol; 2015 May; 142(5):379-80. PubMed ID: 25813188 [No Abstract] [Full Text] [Related]
35. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Sadeghian G; Nilfroushzadeh MA; Iraji F Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205 [TBL] [Abstract][Full Text] [Related]
36. Response of cutaneous leishmaniasis (chiclero's ulcer) to treatment with meglumine antimoniate in Southeast Mexico. Vargas-Gonzalez A; Canto-Lara SB; Damian-Centeno AG; Andrade-Narvaez FJ Am J Trop Med Hyg; 1999 Dec; 61(6):960-3. PubMed ID: 10674678 [TBL] [Abstract][Full Text] [Related]
37. American cutaneous leishmaniasis as a rare imported disease in Europe: a case report favourably treated with antimonial derivatives. Manfredi R; di Bari MA; Calza L; Chiodo F Eur J Epidemiol; 2001; 17(8):793-5. PubMed ID: 12086100 [TBL] [Abstract][Full Text] [Related]
38. Oriental sore: a case report. Asvesti C; Anastassiadis G; Kolokotronis A; Zographakis I Oral Surg Oral Med Oral Pathol; 1992 Jan; 73(1):56-8. PubMed ID: 1603565 [TBL] [Abstract][Full Text] [Related]
39. [Factors associated with treatment failure of cutaneous leishmaniasis with meglumine antimoniate]. Rodrigues AM; Hueb M; Santos TA; Fontes CJ Rev Soc Bras Med Trop; 2006; 39(2):139-45. PubMed ID: 16699638 [TBL] [Abstract][Full Text] [Related]